FOsfomycin for Male Urinary Tract Infection

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2028

Conditions
Urinary Tract InfectionProstatitisCystitis
Interventions
DRUG

Fosfomycun-trometamol

Study of the efficacy and safety of Fosfomycin trometamol as a 14-day treatment using a 3 g sachet every 2 days for 14 days for the treatment of male urinary tract infections in primary care: open-label, non-randomised, multicentre, inter-regional trial.

All Listed Sponsors
collaborator

INSERM UMR1311 DYNAMICURE

UNKNOWN

collaborator

Department of General Practice, Rouen University

UNKNOWN

collaborator

Health Ministry funding (ReSpiR funds)

UNKNOWN

lead

University Hospital, Rouen

OTHER